DaVita (NYSE:DVA) Announces Earnings Results, Beats Expectations By $0.10 EPS

DaVita (NYSE:DVA) posted its quarterly earnings results on Thursday. The company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10, Zacks reports. DaVita had a net margin of 6.53% and a return on equity of 88.18%.

DaVita Stock Up 3.2 %

DaVita stock traded up $5.45 during trading on Thursday, reaching $177.45. 1,001,902 shares of the company’s stock were exchanged, compared to its average volume of 577,411. DaVita has a 52-week low of $118.56 and a 52-week high of $179.60. The firm has a market cap of $14.55 billion, a price-to-earnings ratio of 19.14, a PEG ratio of 0.84 and a beta of 0.94. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The company’s 50-day moving average is $161.15 and its two-hundred day moving average is $157.11.

Analysts Set New Price Targets

Separately, Barclays upped their price target on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, DaVita presently has an average rating of “Hold” and a consensus target price of $161.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.